Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Stephens

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
The Lancet. Infectious Diseases|April 15, 2011
Outer-membrane-vesicle vaccines: old but not forgottenDavid S Stephens
Current Infectious Disease Reports|October 6, 2004
Decline in Invasive Pneumococcal Disease after Use of Protein-polysaccharide Conjugate VaccineDavid S Stephens
The Lancet. Infectious Diseases|October 18, 2016
Boosters for meningococcal B vaccines?David S Stephens
FEMS Microbiology Reviews|January 20, 2007
Conquering the meningococcusDavid S Stephens
Transactions of the American Clinical and Climatological Association|June 21, 2011
Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamicsDavid S Stephens
Current Infectious Disease Reports|October 6, 2004
Trends in Sepsis-related Neonatal MortalityDavid S Stephens
The Journal of Infectious Diseases|February 15, 2008
Vaccines for the unvaccinated: protecting the herdDavid S Stephens
Current Infectious Disease Reports|October 6, 2004
Herd Immunity from Meningococcal Serogroup C Conjugate VaccinationDavid S Stephens
Vaccine|May 30, 2009
Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidisDavid S Stephens
Lancet (London, England)|January 21, 2012
Prevention of serogroup B meningococcal diseaseDavid S Stephens
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
The Lancet. Infectious Diseases|April 15, 2011
Outer-membrane-vesicle vaccines: old but not forgottenDavid S Stephens
Current Infectious Disease Reports|October 6, 2004
Decline in Invasive Pneumococcal Disease after Use of Protein-polysaccharide Conjugate VaccineDavid S Stephens
The Lancet. Infectious Diseases|October 18, 2016
Boosters for meningococcal B vaccines?David S Stephens
FEMS Microbiology Reviews|January 20, 2007
Conquering the meningococcusDavid S Stephens
Transactions of the American Clinical and Climatological Association|June 21, 2011
Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamicsDavid S Stephens
Current Infectious Disease Reports|October 6, 2004
Trends in Sepsis-related Neonatal MortalityDavid S Stephens
The Journal of Infectious Diseases|February 15, 2008
Vaccines for the unvaccinated: protecting the herdDavid S Stephens
Current Infectious Disease Reports|October 6, 2004
Herd Immunity from Meningococcal Serogroup C Conjugate VaccinationDavid S Stephens
Vaccine|May 30, 2009
Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidisDavid S Stephens
Lancet (London, England)|January 21, 2012
Prevention of serogroup B meningococcal diseaseDavid S Stephens
Pageof 15